Osaka, Japan

Eiki Oikawa

This inventor holds 1 USPTO granted patent. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eiki Oikawa. Retrieved from https://idiyas.com/inventor/eiki-oikawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Eiki Oikawa: Innovator in Pharmaceutical Chemistry

Introduction

Eiki Oikawa is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patent work. His expertise and dedication to research have positioned him as a valuable asset in the industry.

Latest Patents

Eiki Oikawa holds a patent for N-[ (R)-1-[3-(4-piperidyl)propionyl]-3-piperidylcarbonyl]-2(S)-acetylamino-β-alanine trihydrate, compositions thereof, and methods for its use. This patent reflects his commitment to advancing pharmaceutical applications and improving therapeutic options.

Career Highlights

Oikawa is currently employed at Fujisawa Pharmaceutical Company, Ltd., where he continues to engage in groundbreaking research. His work at the company has allowed him to explore various aspects of drug development and formulation.

Collaborations

Throughout his career, Eiki Oikawa has collaborated with esteemed colleagues, including Mitsuru Ohkubo and Satoru Kuroda. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Eiki Oikawa's contributions to pharmaceutical chemistry through his patent and collaborative efforts highlight his role as an influential inventor. His work continues to impact the field positively, paving the way for future advancements in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…